Antisense modulation of PTPN2 expression
US6485974B1 · kind B1 · utility
9Cited by
1References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 2001 |
| Grant date | Nov 26, 2002 |
| Priority date | — |
| Expiry date | May 18, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of PTPN2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTPN2. Methods of using these compounds for modulation of PTPN2 expression and for treatment of diseases associated with expression of PTPN2 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.